From: Malignancy validation in a United States registry of rheumatoid arthritis patients
Total CORRONA Population | Total CORRONA Patients Without Malignancy | Total CORRONA Patients With Malignancies | P-Values | |
---|---|---|---|---|
(N = 20,839) | (N = 20,438) | (N = 401)** | ||
Age (Mean, SD) | 57.7 (13.6) | 57.6 (13.9) | 65.2 (11.0) | <.0001 |
Female Gender (N, %) | 15,135 (72.8%) | 14,883 (73.0%) | 252 (62.8%) | <.0001 |
Race/Ethnicity (N, %) | ||||
White | 17,292 (84.0%) | 16,940 (84.0%) | 352 (88.7%) | 0.0005 |
Hispanic | 1,291 (6.3%) | 1,275 (6.3%) | 16 (4.0%) | |
Black | 1,248 (6.1%) | 1,238 (6.1%) | 10 (2.5%) | |
Asian | 344 (1.7%) | 340 (1.7%) | 4 (1.0%) | |
Other | 418 (2.0%) | 403 (2.0%) | 15 (3.8%) | |
Seropositivity (N, %) | 7,400 (67.7%) | 7,224 (67.6%) | 176 (70.7%) | 0.31 |
RA Disease Duration at Enrollment in CORRONA (mean years, SD) | 9.56 (9.8) | 9.49 (9.8) | 12.56 (11.3) | <.0001 |
Years of Follow-up After CORRONA Enrollment Until Report of Cancer* (mean, SD) | 1.76 (1.6) | 1.75 (1.8) | 2.26 (1.7) | <.0001 |